Annals of Internal Medicine
June 2021 Volume 174, Issue 6
http://annals.org/aim/issue
Ideas and Opinions
Risk Compensation and COVID-19 Vaccines
FREE
Brit Trogen, MD, MS, Arthur Caplan, PhD
Pages:858–859
Annals of Internal Medicine
June 2021 Volume 174, Issue 6
http://annals.org/aim/issue
Ideas and Opinions
Risk Compensation and COVID-19 Vaccines
FREE
Brit Trogen, MD, MS, Arthur Caplan, PhD
Pages:858–859
Annals of Internal Medicine
June 2021 Volume 174, Issue 6
http://annals.org/aim/issue
Reviews
Antibody Response After SARS-CoV-2 Infection and Implications for Immunity – A Rapid Living Review
FREE
Irina Arkhipova-Jenkins, MD, MBA, Mark Helfand, MD, MPH, Charlotte Armstrong, BA, Emily Gean, PhD, … et al.
Pages:811–821
Annals of Internal Medicine
June 2021 Volume 174, Issue 6
http://annals.org/aim/issue
Racial Disparities in COVID-19 Testing and Outcomes
Retrospective Cohort Study in an Integrated Health System
FREE
Gabriel J. Escobar, MD, Alyce S. Adams, PhD, Vincent X. Liu, MD, MS, Lauren Soltesz, MS, … et al.
Pages:786–793
Annals of Internal Medicine
June 2021 Volume 174, Issue 6
http://annals.org/aim/issue
Original Research
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19
FREE
Shannon Wongvibulsin, PhD, Brian T. Garibaldi, MD, MEHP, Annukka A.R. Antar, MD, PhD, … et al.
Pages:777–785
BMJ Global Health
May 2021 – Volume 6 – Suppl 3
https://gh.bmj.com/content/6/Suppl_3
Social and ethical issues of poor quality and poor use of medical products
Practice
Elusive quality: the challenges and ethical dilemmas faced by international non-governmental organisations in sourcing quality assured medical products (28 May, 2021)
Katherine Enright
BMJ Global Health
May 2021 – Volume 6 – Suppl 3
https://gh.bmj.com/content/6/Suppl_3
Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia (28 May, 2021)
BMJ Global Health
May 2021 – Volume 6 – Suppl 3
https://gh.bmj.com/content/6/Suppl_3
Monitoring, reporting and regulating medicine quality: tensions between theory and practice in Tanzania (28 May, 2021)
Heather Hamill, Elizabeth David-Barrett, Joseph Rogathe Mwanga, Gerry Mshana, Kate Hampshire
BMJ Global Health
May 2021 – Volume 6 – Suppl 3
https://gh.bmj.com/content/6/Suppl_3
Original research
Implementing pharmaceutical track-and-trace systems: a realist review (28 May, 2021)
Joeke Kootstra, Tineke Kleinhout-Vliek
BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 19 Jun 2021)
Advancing discussion of ethics in mixed methods health services research
To describe the ethical issues and experiences of scientists conducting mixed methods health services research and to advance empirical and conceptual discussion on ethical integrity in mixed methods health research… Mixed methods health researchers reported encountering ethical issues often yet varying levels of difficulty and effectiveness in the strategies used to mitigate ethical issues. This study highlights some of the unique challenges faced by mixed methods researchers to plan for and appropriately respond to arising ethical issues such as managing participant burden and confidentiality across data sources and utilizing effective communication and dissemination strategies particularly when working with a multidisciplinary research team. As one of the first empirical studies to examine mixed methods research ethics, our findings highlight the need for greater attention to ethics in health services mixed methods research and training.
Authors: Nicole A. Stadnick, Cheryl N. Poth, Timothy C. Guetterman and Joseph J. Gallo
Citation: BMC Health Services Research 2021 21:577
Content type: Research
Published on: 15 June 2021
BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 19 Jun 2021)
Hospital-based prospective study of pertussis in infants and close contacts in Tehran, Iran
Pertussis remain a global health concern, especially in infants too young to initiate their vaccination. Effective vaccination and high coverage limit the circulation of the pathogen, yet duration of protectio…
Authors: Gaelle Noel, Masoumeh Nakhost Lotfi, Sajedeh Mirshahvalad, Sedaghatpour Mahdi, David Tavel, Seyed M. Zahraei, Roxana Mansour Ghanaie, Tahereh Heidary, Aliahmad Goudarzi, Azardokht Kazemi, Abdollah Karimi, Alireza Nateghian, Mohand Ait-Ahmed, Nicole Guiso, Fereshteh Shahcheraghi and Fabien Taieb
Citation: BMC Infectious Diseases 2021 21:586
Content type: Research
Published on: 18 June 2021
BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 19 Jun 2021)
Vaccine completion and infectious diseases screening in a cohort of adult refugees following resettlement in the U.S.: 2013–2015
Refugees are frequently not immune to vaccine-preventable infections. Adherence to consensus guidelines on vaccination and infectious diseases screening among refugees resettling in the U.S. is unknown. We sou…
Authors: Amir M. Mohareb, Bryan Brown, Kevin S. Ikuta, Emily P. Hyle and Aniyizhai Annamalai
Citation: BMC Infectious Diseases 2021 21:582
Content type: Research
Published on: 16 June 2021
BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 19 Jun 2021)
Moral distress and ethical climate in intensive care medicine during COVID-19: a nationwide study
Authors: Moniek A. Donkers, Vincent J. H. S. Gilissen, Math J. J. M. Candel, Nathalie M. van Dijk, Hans Kling, Ruth Heijnen-Panis, Elien Pragt, Iwan van der Horst, Sebastiaan A. Pronk and Walther N. K. A. van Mook
Content type: Research
17 June 2021
BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 19 Jun 2021)
Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout
As in many countries, quantifying COVID-19 spread in Indonesia remains challenging due to testing limitations. In Java, non-pharmaceutical interventions (NPIs) were implemented throughout 2020. However, as a v…
Authors: Bimandra A. Djaafara, Charles Whittaker, Oliver J. Watson, Robert Verity, Nicholas F. Brazeau, Widyastuti, Dwi Oktavia, Verry Adrian, Ngabila Salama, Sangeeta Bhatia, Pierre Nouvellet, Ellie Sherrard-Smith, Thomas S. Churcher, Henry Surendra, Rosa N. Lina, Lenny L. Ekawati…
Citation: BMC Medicine 2021 19:146
Content type: Research article
Published on: 18 June 2021
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 19 Jun 2021)
“Saint Google, now we have information!”: a qualitative study on narratives of trust and attitudes towards maternal vaccination in Mexico City and Toluca
Maternal vaccination is key to decreasing maternal and infant mortality globally. Yet perceptions about maternal vaccines and immunization among pregnant women are often understudied, particularly in low- and …
Authors: Clarissa Simas, Heidi J. Larson and Pauline Paterson
Citation: BMC Public Health 2021 21:1170
Content type: Research
Published on: 18 June 2021
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 19 Jun 2021)
Structural inequities in seasonal influenza vaccination rates
Influenza immunization is a highly effective method of reducing illness, hospitalization and mortality from this disease. However, influenza vaccination rates in the U.S. remain below public health targets and…
Authors: Lara I. Brewer, Mark J. Ommerborn, Augustina Le Nguyen and Cheryl R. Clark
Citation: BMC Public Health 2021 21:1166
Content type: Research
Published on: 17 June 2021
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 19 Jun 2021)
The protection motivation theory for predict intention of COVID-19 vaccination in Iran: a structural equation modeling approach
Many efforts are being made around the world to discover the vaccine against COVID-19. After discovering the vaccine, its acceptance by individuals is a fundamental issue for disease control. This study aimed …
Authors: Alireza Ansari-Moghaddam, Maryam Seraji, Zahra Sharafi, Mahdi Mohammadi and Hassan Okati-Aliabad
Citation: BMC Public Health 2021 21:1165
Content type: Research
Published on: 17 June 2021
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 19 Jun 2021)
Development of a theory-based HPV vaccine promotion comic book for East African adolescents in the US
Human Papillomavirus (HPV) vaccine uptake is low among East African adolescents in the US. Adolescents’ preferences influence HPV vaccine decisions, yet few interventions exist that address East African adoles…
Authors: Isabelle Celentano, Rachel L. Winer, Sou Hyun Jang, Anisa Ibrahim, Farah Bille Mohamed, John Lin, Fanaye Amsalu, Ahmed A. Ali, Victoria M. Taylor and Linda K. Ko
Citation: BMC Public Health 2021 21:1137
Content type: Research article
Published on: 14 June 2021
Developing World Bioethics
Volume 21, Issue 1 Pages: i, 1-54 March 2021
https://onlinelibrary.wiley.com/toc/14718847/current
Special Issue: Conscientious objection to termination of pregnancy in the global south: legal and ethical challenges
Issue Edited by: Anita Kleinsmidt
Forum for Development Studies
Volume 48, 2021 – Issue 2
http://www.tandfonline.com/toc/sfds20/current
Article
Politics of Vaccine Nationalism in India: Global and Domestic Implications
Niladri Chatterjee, Zaad Mahmood & Eleonor Marcussen
Pages: 357-369
Published online: 09 May 2021
Abstract
The fight against the Covid-19 pandemic has shifted from finding a cure to acquiring vaccines and organizing vaccination. The race for vaccination has exacerbated tendencies of hoarding, particularly among rich countries, academically expressed as vaccine nationalism. Vaccine nationalism is harmful to the global effort in the fight against the pandemic. India in contrast has been quite generous to its neighbours in sharing vaccines pursuing its own form of vaccine nationalism. The strategy pursued by India can be read as an effort to gloss over the failures in initial pandemic management, to improve diplomatic leverage and reinforce an idiom of nationalism. Such an effort however has potentially harmful effects undermining trust in the vaccine as well as in the government. The politicization of vaccine also has counterproductive outcomes for democratic practices within the country.
Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 19 Jun 2021]
Landscape and selection of vaccine epitopes in SARS-CoV-2
Early in the pandemic, we designed a SARS-CoV-2 peptide vaccine containing epitope regions optimized for concurrent B cell, CD4+ T cell, and CD8+ T cell stimulation. The rationale for this design was to drive bot…
Authors: Christof C. Smith, Kelly S. Olsen, Kaylee M. Gentry, Maria Sambade, Wolfgang Beck, Jason Garness, Sarah Entwistle, Caryn Willis, Steven Vensko, Allison Woods, Misha Fini, Brandon Carpenter, Eric Routh, Julia Kodysh, Timothy O’Donnell, Carsten Haber…
Citation: Genome Medicine 2021 13:101
Content type: Research
Published on: 14 June 2021
Health Research Policy and Systems
http://www.health-policy-systems.com/content
[Accessed 19 Jun 2021]
A cross-country comparison of malaria policy as a premise for contextualized appropriation of foreign aid in global health
Foreign aid continues to play an essential role in health sector development in low-resource countries, particularly in terms of providing a vital portion of their health expenditures. However, the relationshi…
Authors: Tomas Jezek and Oluwaseun Adebayo Bamodu
Citation: Health Research Policy and Systems 2021 19:93
Content type: Research
Published on: 14 June 2021
Human Gene Therapy
Volume 32, Issue 11-12 / June 2021
https://www.liebertpub.com/toc/hum/32/11-12
Commentary
Primum Non Nocere: Should Gene Therapy Be Used to Prevent Potentially Fatal Disease but Enable Potentially Destructive Behavior?
Inmaculada de Melo-Martin and Ronald G. Crystal
Pages:529–534
Published Online:26 April 2021
https://doi.org/10.1089/hum.2021.039
Human Gene Therapy
Volume 32, Issue 11-12 / June 2021
https://www.liebertpub.com/toc/hum/32/11-12
Review Free
Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination
Atil Bisgin, Ahter D. Sanlioglu, Yunus Emre Eksi, Thomas S. Griffith, and Salih Sanlioglu
Pages:541–562
Published Online:29 April 2021
https://doi.org/10.1089/hum.2021.052
Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/
Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies, non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported. Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.
International Journal of Infectious Diseases
Volume 107 p1-310
https://www.ijidonline.com/current
Editorials
World Meningitis Day and the World Health Organization’s roadmap to defeat bacterial meningitis in the COVID-19 pandemic era
Tatiana Castro Abreu Pinto, Natalia Silva Costa, Laura Maria Andrade Oliveira
Published online: April 28, 2021
p219-220
International Journal of Infectious Diseases
Volume 107 p1-310
https://www.ijidonline.com/current
Coronavirus (COVID-19) Collection
Impact of COVID-19 on immunization of Brazilian infants
João Guilherme Alves, José Natal Figueiroa, Marcelo Luis Urquia
Published online: May 04, 2021
p252-253
International Journal of Infectious Diseases
Volume 107 p1-310
https://www.ijidonline.com/current
Post-vaccination cases of COVID-19 among healthcare workers at Siloam Teaching Hospital, Indonesia
Cucunawangsih Cucunawangsih, Ratna Sari Wijaya, Nata Pratama Hardjo Lugito, Ivet Suriapranata
Published online: May 13, 2021
p268-270
JAMA
June 15, 2021, Vol 325, No. 23, Pages 2327-2410
https://jamanetwork.com/journals/jama/currentissue
Original Investigation
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
Ai-ris Y. Collier, MD; Katherine McMahan, MS; Jingyou Yu, PhD; et al.
free access has active quiz
JAMA. 2021;325(23):2370-2380. doi:10.1001/jama.2021.7563
This study assesses the immunogenicity of the current COVID-19 mRNA vaccines in pregnant and lactating women against both the original SARS-CoV-2 USA-WA1/2020 strain as well as against the B.1.1.7 and B.1.351 variants of concern.
JAMA
June 15, 2021, Vol 325, No. 23, Pages 2327-2410
https://jamanetwork.com/journals/jama/currentissue
Research Letter
Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021
Michael Daly, PhD; Andrew Jones, PhD; Eric Robinson, PhD
free access
JAMA. 2021;325(23):2397-2399. doi:10.1001/jama.2021.8246
This online survey study of US adults characterizes trends in coronavirus vaccine hesitancy and public trust in vaccination before and after COVID-19 vaccine availability in the US.
JAMA
June 15, 2021, Vol 325, No. 23, Pages 2327-2410
https://jamanetwork.com/journals/jama/currentissue
Viewpoint
Restoring Vaccine Diplomacy
Peter J. Hotez, MD, PhD; K. M. Venkat Narayan, MD
free access has active quiz
JAMA. 2021;325(23):2337-2338. doi:10.1001/jama.2021.7439
This Viewpoint discusses the importance of equitable international collaboration, innovative manufacturing and supply chain development, and shared governance to provide the billions of COVID-19 vaccine doses to the world’s low-income and low-resource populations that will be necessary to control the coronavirus pandemic.
JAMA Network
COVID-19 Update June 19, 2021
These articles on COVID-19 were published across the JAMA Network in the last week.
Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396
Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…
Journal of Infectious Diseases
Volume 223, Issue 9, 1 May 2021
https://academic.oup.com/jid/issue/223/9
BACTERIA
The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics
Michael S Sinha, John H Powers, III, Aaron S Kesselheim
The Journal of Infectious Diseases, Volume 223, Issue 9, 1 May 2021, Pages 1506–1509, https://doi.org/10.1093/infdis/jiaa536
Though antimicrobial resistance is a public health concern, the basis of approval for many new antibiotics does not distinguish them from older products. We suggest a more tailored incentive structure for antibiotic development, focused on clinical benefit and patient outcomes.
The Lancet
Jun 19, 2021 Volume 397 Number 10292 p2309-2438, e16
https://www.thelancet.com/journals/lancet/issue/current
Editorial
Protecting refugees during the COVID-19 pandemic
The Lancet
his World Refugee Day, June 20, coincides with 70 years of the 1951 Refugee Convention, a multilateral treaty that shaped the standards that provide the bedrock of international protection for refugees against discrimination and violation of their human rights. The COVID-19 pandemic has weighed heavily on the 26·3 million refugees worldwide today. International guidelines and national programmes to curb transmission have not always considered the needs of refugees living in densely populated shelters without water and sanitation facilities. The economic harms of the pandemic disproportionately affect the poorest people, applications for asylum and resettlement were disrupted by lockdowns, and refugees have been blamed for spreading SARS-CoV-2. It is timely to consider whether the spirit of the Refugee Convention is being upheld and whether refugees are getting the protection to which they are entitled.
Vaccination is the central pillar of global recovery from the COVID-19 pandemic, but most refugees face a double burden of vaccine inequity. First, 86% of refugees live in low-income and middle-income countries (LMICs), which are heavily reliant on COVAX, an initiative set up to ensure equitable access to COVID-19 vaccines and built on principles of solidarity. But as a World Report in this issue explains, weaknesses in design and selfish political motivations have led to the failure of this vision. As of June 14, only 87 million doses have been shipped to 131 countries through COVAX, far below targets. Second, many LMICs that have received vaccines are not prioritising refugees. For example, in Bangladesh, where 2·5% of the population is fully vaccinated, not a single dose has been administered in Cox’s Bazar. In the world’s largest refugee camp, non-pharmaceutical measures remain the sole tool to prevent major outbreaks.
A report by the ECDC shows how even in high-income countries with advanced immunisation programmes that include (and in some cases prioritise) refugees, barriers to care and vaccination still exist. Uptake of vaccination is low, and the report presents evidence that vaccine acceptance in European migrant populations is undermined by communication challenges, discrimination and stigma, fear of deportation, and a loss of trust in authorities. These issues partly explain why refugees and asylum seekers more generally have suboptimal access to primary health-care services in the region. Language barriers contribute to a deficit of accurate information, and social marginalisation has allowed misinformation to spread, fuelling vaccine hesitancy. Engaging with refugee communities to understand their concerns and studying barriers to vaccination will be essential for protecting all.
Indeed, there is no shortage of research needs in studies of refugees, migration, and health. To this end, building on the recommendations of the UCL–Lancet Commission on Migration and Health, the Lancet Migration European Regional Hub launches on June 22, to fill a major gap in pan-European migration and health research initiatives. It will address research needs, foster collaboration, and bring evidence-based approaches to public discourse and policy around migration and health.
But addressing these issues is not simply a matter of acquiring more and better evidence. Political and moral discussions about migration and refugees are taking place too. All countries, including wealthy ones, have suffered grievously because of COVID-19. Millions of people have died, health systems have been overwhelmed, and economies have been shattered. A wish to turn inward at such a moment is understandable. Even US Vice-President Kamala Harris warned would-be Guatemalan migrants not to come to the USA earlier this month. How can a broken nation look beyond its own citizens? And how do we square this dilemma with the need to protect refugees?
The clearest argument is that refugees and migrants make huge contributions to society. Most international migrants who are refugees live in urban areas, where their work on the front-lines of health care and hospitality is central to pandemic response and recovery. But just as important, is health’s potential to be a unifying force. In the UK, the Government is reducing the foreign aid budget from 0·7% to 0·5% of gross national income. This decision has prompted not just criticism from humanitarian agencies and opposition parties, but also a recent rebellion from senior members of its own party. What unites them is a basic agreement that policy should not condemn individuals to death or illness. Viewed this way, health becomes an instrument to cut across political divides. In an age when the world faces competing and reinforcing challenges, of climate change, conflict, pandemics, mass forced migration, and polarised political responses, such an instrument could be invaluable.
The Lancet
Jun 19, 2021 Volume 397 Number 10292 p2309-2438, e16
https://www.thelancet.com/journals/lancet/issue/current
Comment
Disease surveillance for the COVID-19 era: time for bold changes
Oliver W Morgan, et al.
Lancet Global Health
Jun 2021 Volume 9 Number 6 e721-e879
https://www.thelancet.com/journals/langlo/issue/current
Viewpoint Online First
Polio eradication at the crossroads
Konstantin Chumakov, PhD , Ellie Ehrenfeld, PhD †, ., Prof Eckard Wimmer, PhD
Summary
The Global Polio Eradication Initiative, launched in 1988 with anticipated completion by 2000, has yet to reach its ultimate goal. The recent surge of polio cases urgently calls for a reassessment of the programme’s current strategy and a new design for the way forward. We propose that the sustainable protection of the world population against paralytic polio cannot be achieved simply by stopping the circulation of poliovirus but must also include maintaining high rates of population immunity indefinitely, which can be created and maintained by implementing global immunisation programmes with improved poliovirus vaccines that create comprehensive immunity without spawning new virulent viruses. The proposed new strategic goal of eradicating the disease rather than the virus would lead to a sustainable eradication of poliomyelitis while simultaneously promoting immunisation against other vaccine-preventable diseases.
Nature
Volume 594 Issue 7863, 17 June 2021
https://www.nature.com/nature/volumes/594/issues/7863
Editorial
| 16 June 2021
Research collaborations bring big rewards: the world needs more
A special issue on COVID-era research collaboration highlights the benefits to science and society of working across borders, cultures and disciplines.
Nature
Volume 594 Issue 7863, 17 June 2021
https://www.nature.com/nature/volumes/594/issues/7863
Editorial | 16 June 2021
COVID has shown the power of science–industry collaboration
But a thriving relationship needs clearer rules around data ownership and intellectual property – and public trust in the process.
Nature
Volume 594 Issue 7863, 17 June 2021
https://www.nature.com/nature/volumes/594/issues/7863
Article | 12 May 2021
The epidemiological impact of the NHS COVID-19 app
Statistical analysis of COVID-19 transmission among users of a smartphone-based digital contact-tracing app suggests that such apps can be an effective measure for reducing disease spread.
Chris Wymant, Luca Ferretti, Christophe Fraser
Nature Human Behaviour
Volume 5 Issue 6, June 2021
https://www.nature.com/nathumbehav/volumes/5/issues/6
Article | 18 February 2021
Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves in Chinese cities
Vaccination combined with physical distancing can suppress resurgences without relying on stay-at-home restrictions. To achieve herd immunity, cities with a higher population density require more stringent physical distancing measures with longer durations.
Bo Huang, Jionghua Wang, Shengjie Lai
Nature Human Behaviour
Volume 5 Issue 6, June 2021
https://www.nature.com/nathumbehav/volumes/5/issues/6
Article | 28 April 2021
Anti-intellectualism and the mass public’s response to the COVID-19 pandemic
Merkley and Loewen find that anti-intellectualism (distrust in experts and intellectuals) is linked to COVID-19 (mis)perceptions, compliance with public health directives and information search using survey and experimental data from Canada.
Eric Merkley, Peter John Loewen
Nature Medicine
Volume 27 Issue 6, June 2021
https://www.nature.com/nm/volumes/27/issues/6
Editorial | 24 May 2021
To curb COVID-19, global health must go local
The surge in COVID-19 cases in India and Brazil highlights the need to improve vaccine manufacturing capacity and investment in public health at the local level.
Nature Medicine
Volume 27 Issue 6, June 2021
https://www.nature.com/nm/volumes/27/issues/6
Review Article | 17 May 2021
Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries
A review of COVID-19 responses in 28 selected countries identifies elements of highly effective public health responses and offers recommendations toward strengthening health systems resilience.
Victoria Haldane, Chuan De Foo, Helena Legido-Quigley
Nature Medicine
Volume 27 Issue 6, June 2021
https://www.nature.com/nm/volumes/27/issues/6
Article | 19 April 2021
COVID-19 dynamics after a national immunization program in Israel
A retrospective analysis of data from the Israeli Ministry of Health collected between 28 August 2020 and 24 February 2021 documents the real-life effect of a national vaccination campaign on the pandemic dynamics.
Hagai Rossman, Smadar Shilo, Eran Segal
New England Journal of Medicine
June 17, 2021 Vol. 384 No. 24
http://www.nejm.org/toc/nejm/medical-journal
Original Articles
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons T.T. Shimabukuro and Others
New England Journal of Medicine
June 17, 2021 Vol. 384 No. 24
http://www.nejm.org/toc/nejm/medical-journal
Editorials
mRNA Covid-19 Vaccines in Pregnant Women L.E. Riley
PharmacoEconomics
Volume 39, issue 6, June 2021
https://link.springer.com/journal/40273/volumes-and-issues/39-6
Themed issue : Economic Burden of Major Depressive Disorders
Introduction to the Special Issue of PharmacoEconomics on Major Depressive Disorders
Authors; Paul E. Greenberg, Tammy Sisitsky
Content type: Editorial
Published: 13 May 2021
PLoS One
http://www.plosone.org/
[Accessed 19 Jun 2021]
Timeliness of routine childhood vaccination in low- and middle-income countries, 1978–2021: Protocol for a scoping review to map methodologic gaps and determinants
Oghenebrume Wariri, Uduak Okomo, Yakubu Kevin Kwarshak, Kris A. Murray, Chris Grundy, Beate Kampmann
Study Protocol | published 17 Jun 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0253423
PLoS One
http://www.plosone.org/
[Accessed 19 Jun 2021]
Policy liberalism and source of news predict pandemic-related health behaviors and trust in the scientific community
Madeleine Reinhardt, Matthew B. Findley, Renee A. Countryman
Research Article | published 17 Jun 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0252670
PLoS One
http://www.plosone.org/
[Accessed 19 Jun 2021]
COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans
Rachel Strodel, Lauren Dayton, Henri M. Garrison-Desany, Gabriel Eber, Chris Beyrer, Joyell Arscott, Leonard Rubenstein, Carolyn Sufrin
Research Article | published 15 Jun 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0253208